|
101. Sandhu MS, Luben R, Khaw KT. Self reported non-unsulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study . J Epidemiol Community Health 2001, 55: 804–805. 102. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, Lazovich D, Folsom AR. Diabetes and endometrial cancer in the Iowa women`s health study. Cancer Epidemiol Biomarkers Prev 2001, 10: 611–616. 103. Cale EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults . Cancer Causes Control 1998, 9: 403–410. 104. Finegold SM, Sutter VL, Sugihara PT, Elder HA, Lehmann SM, Phillips RL. Fecal microbial flora in Seventh Day Adventist Populations and control subjects . Am J Clin Nutr 1977; 30: 1781–1792. 105. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61: 3202–3207. 106. Goldin PR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984; 39: 756–761. 107. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group . Urol Int 1992; 49: 125–129. 108. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995; 27: 104–109. 109. Flint HJ. Nutr Rev 2012; 70 Suppl1: S10–S13 (World Cancer Report 2014 ). 110. Tremaroli V, Backhed F. Nature 2012; 489: 242–249 (World Cancer Report 2014 ). 111. Commane D, Hughes R, Shortt C, Rowland I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res /Fundam Mol Mech Mutagen 2005; 591: 276–89. 112. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, Kumar P, Poddar D, Aggarwal P, Henry C. Cancer-preventing attributes of probiotics: an update . Int J Food Sci Nutr 2010; 61: 473–96. 113. de Moreno de LeBlanc A, Perdigon G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc 2010; 69: 421–8. 114. Mohammadi R, Mortazavian AM. Review article: technological aspects of prebiotics in probiotic fermented milks. Food Rev Intl 2010; 27: 192–212. — 24 —
|